Science
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002 – PR Newswire India
/PRNewswire/ — Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus…
The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phase I trial was designed to evaluate JMB2002’s tolerability, safety, pharmacokinetic characteristics and immunogenicity…
Continue Reading
-
General23 hours agoWest Indies vs Australia live: Second Test, day two from Grenada
-
Noosa News12 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
Noosa News15 hours agoNow Open: The Family Behind Merlo Coffee Continues Its Legacy in Bowen Hills with the Arrival of Milano Bakehouse
-
General8 hours agoCan the world be governed without the US? • Inside Story